The 20 Best Plasmacytoma Doctors Near Me in New Brunswick, NJ

Saad Usmani is a Hematologist and an Oncologist practicing medicine in Montvale, New Jersey. Dr. Usmani is rated as an Elite provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Usmani is currently accepting new patients.

Dr. Manish J. Dave is the Director of Blood Disorders and Hematologic Malignancies for the Hackensack Meridian Health Central Region. He is an experienced, full-time physician who is triple board-certified in internal medicine, hematology, and medical oncology. Dr. Dave sees patients at JFK University Medical Center. He has a strong academic foundation and treats patients with a variety of conditions related to malignant hematology, solid oncology, and benign hematology. His career opportunities have allowed him to present numerous cases at weekly tumor boards and serve as principal investigator for clinical trials. Dr. Dave is involved with clinical research (focused on malignant hematology) and he has a multitude of peer-reviewed publications. He is actively involved in teaching medical students and housestaff through clinical rotations, serving as a preceptor, and presenting PowerPoints at Journal Club, Morning Report, and Noon Conferences. He has held a number of leadership roles in the past. He was the Resident Representative of the Cancer Committee at Rush University Medical Center, Hematology Chief Fellow at Albert Einstein College of Medicine, and he served as the Chair of the Blood Transfusion Committee at Putnam Hospital. Dr. Dave served on the Cold Agglutinin Advisory Board for Sanofi Pharmaceuticals, and he is currently on the Speaker Bureau for Sanofi and Merck. He has presented his clinical and basic science research at renowned national research conferences (including the ASCO and ACP annual meetings). He has been a clinical speaker for Reblozyl at Bristol Myers Squibb. Dr. Dave has been a speaker at a multitude of national medical conferences. Dr. Dave's philosophy is to treat every patient as he would treat his own family member. He strives to provide the best and newest available therapies for his patients. He has extensive experience in procedural skills, including bone marrow aspirates and biopsies and peripheral smear review. Dr. Dave has received multiple awards for superb patient feedback and outstanding clinical skills. He received the Milli Award in 2017 and Top Hematology & Oncology Physician Award in 2018 and 2024. He has volunteered and helped to coordinate medical care for the underserved in Winston-Salem, NC (through the DEAC Clinic and “Share the Health” Fair) and through an overseas medical mission trip (Child Family Health International) in Mumbai. Dr. Dave has had the privilege of working with a multi-disciplinary team in caring for cancer patients, and he strives to deliver the best evidence-based care possible. Dr. Dave is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, Pulmonary Embolism, and Bone Marrow Aspiration. Dr. Dave is board certified in Internal Medicine, Hematology, and Medical Oncology. Dr. Dave is currently accepting new patients.

Noa Biran is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Biran is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Plasmacytoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Biran is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.

David Siegel is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Siegel is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, and Schnitzler Syndrome. Dr. Siegel is board certified in American Board Of Internal Medicine.

David Vesole is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Vesole is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Vesole is board certified in American Board Of Internal Medicine.

Ashish Khot, MD, is a fellowship-trained physician specializing in hematology/oncology with Atlantic Medical Group (AMG). Board-certified in hematology and medical oncology by the American Board of Internal Medicine, he has clinical expertise in diagnosing and treating blood disorders including anemia, leukemia, lymphoma and cancers of various organs, particularly lung, genitourinary, gastrointestinal and thoracic malignancies.Dr. Khot embraces a patient-centric approach, educating and empowering his patients and their families to make well-informed decisions regarding their health care. He strongly believes in fostering open communication among patients, their caregivers, and all collaborating physicians, ensuring that their care remains seamlessly coordinated throughout their challenging medical journeys.After earning his medical degree at Grant Medical College in Mumbai, India, Dr. Khot performed an internal medicine residency at St. Luke’s-Roosevelt Medical Center (now called Mt. Sinai West/Morningside) in New York City. He then received specialized training in a hematology and oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.In addition to his clinical roles, Dr. Khot is the regional medical director, eastern region at Atlantic Medical Group, overseeing multiple subspecialist clinicians and pediatric practices. He is the associate medical director for GU oncology for community oncology given his special interest in genitourinary cancer. He is a national speaker on bladder and kidney cancers. He serves on several Atlantic Health System committees, including the Overlook Medical Center Blood Bank and Transfusion Committee, as well as the Union Essex Regional Council, AMG Nomination Committee and AMG Health Equity Committee. He regularly lectures and provides teaching rotations for IM and family medicine residents and medical students at Atlantic Health System hospitals.Dr. Ashish Khot is consistently recognized as a “Top Doctor” by New Jersey Monthly magazine by his peers. He is multilingual, speaking fluent Hindi and Marathi, among other languages. Dr. Khot is a participating provider of the Atlantic Accountable Care Organization. Dr. Khot is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia, and Urothelial Cancer. Dr. Khot is board certified in American Board Of Internal Medicine. Dr. Khot is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration. Dr. Cherry is board certified in American Board Of Internal Medicine. Dr. Cherry is currently accepting new patients.

Israel Grossman is an Oncologist practicing medicine in Livingston, New Jersey. Dr. Grossman is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Plasmacytoma, Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration. Dr. Grossman is currently accepting new patients.

Neha Korde is a Hematologist and an Oncologist practicing medicine in Montvale, New Jersey. Dr. Korde is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Korde is currently accepting new patients.

Pooja Phull is a Hematologist Oncology provider practicing medicine in Hackensack, New Jersey. Dr. Phull is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Phull is board certified in American Board Of Internal Medicine and Hematology.

William Derosa is a Hematologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Derosa is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Plasmacytoma, Small Lymphocytic Lymphoma (SLL), Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Derosa is board certified in American Board Of Internal Medicine. Dr. Derosa is currently accepting new patients.

Harsh Parmar is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Parmar is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Parmar is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.

"Dr. Mona Karim is vice chair of the radiation oncology department of Morristown Medical Center. Her major clinical and research interests include breast, gastrointestinal, head and neck, thoracic, and pediatric cancers. Dr. Karim's other areas of clinical interest are breast brachytherapy and stereotactic radiation. She received her bachelor of arts degree, cum laude, from Harvard University and her medical degree from Albert Einstein College of Medicine, including a one year American Heart Association Medical Student Research Fellowship. Her post-doctoral training was in radiation oncology at the Columbia-Presbyterian Medical Center. Previously, Dr. Karim was assistant professor at the Department of Radiation Oncology, UMDNJ - New Jersey Medical School. Her responsibilities included the clinical practice in radiation oncology and preceptorship of medical students. Her research has been published in the Journal of Molecular Carcinogenesis and the Einstein Quarterly Journal of Biology and Medicine. She is a member of The American Society for Therapeutic Radiology and Oncology (ASTRO), American Society for Clinical Oncology (ASCO), Children's Oncology Group (COG), and Physicians for Human Rights. Among recognition from her peers, Dr. Mona Karim is a multiple-year recipient of the ""Best Doctors in America?"" award. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization.". Dr. Karim is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Intraductal Papilloma, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Karim is board certified in American Board Of Radiology. Dr. Karim is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS). Dr. Huannou is board certified in American Board Of Internal Medicine. Dr. Huannou is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.

Andrew Greenberg is a Radiation Oncologist practicing medicine in Monroe Township, New Jersey. Dr. Greenberg is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Familial Prostate Cancer, and Posterior Fossa Tumor. Dr. Greenberg is board certified in Radiation Oncology, American Board Of Radiology.

James R. Wong, MD, is a radiation oncologist and founder and medical director of the Leonard B. Kahn Head and Neck Cancer Institute at Morristown Medical Center. He specializes in treating head and neck cancers, nasopharyngeal cancer, breast cancer, gastrointestinal cancer, brain tumors and prostate cancer. In 1997, Dr. Wong was named chair of Radiation Oncology at Morristown Medical Center where he presided over the reorganization and development of the new Department of Radiation Oncology. A year later, he was appointed associate clinical professor of radiation oncology at Columbia University, College of Physicians and Surgeons. In 2004, he was appointed by New Jersey Governor Jim McGreevey to the task force on the Prevention, Detection and Treatment of Cancer.Recently, Dr. Wong has developed an interest in incorporating Integrative Medicine and complementary supportive care in the treatment and recovery plans for his patients. Dr. Wong has launched “Integrate to Wellness,” a ten-week program using therapies such as acupuncture and stress management. Before arriving at Atlantic Health System, Dr. Wong served as assistant professor of radiology at the New York Hospital, Cornell University Medical College. He was also the director of radiation oncology fellows and the director of radiation oncology research at the New York Hospital/Cornell Medical Center. At the Stich Radiation Center of New York Hospital, he was in charge of radiation therapy for brain tumors and stereotactic radiosurgery.Graduating summa cum laude from Harvard College, Dr. Wong received his medical degree from Harvard Medical School where he became one of the few honor graduates of his year. He practiced internal medicine at the New England Deaconess Hospital, Harvard Medical School, and continued on for four more years of specialty training in radiation oncology at the Harvard Joint Center for Radiation Therapy. During his 15 years at Harvard, he published many articles in leading scientific journals, including Proceedings of the National Academy of Science, Cell, Journal of Biochemistry, and Cancer Research.Dr. Wong has been selected as one of the “Top Prostate Cancer Specialists” in the United States and is considered a pioneer of image-guided radiation therapy. He was elected by his peers for inclusion in “Best Doctors in America®” for five consecutive years. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Laryngeal Cancer, Thymic Epithelial Tumor, and Familial Prostate Cancer. Dr. Wong is board certified in American Board Of Radiology. Dr. Wong is currently accepting new patients.

Tamara Lacouture is a Radiation Oncologist practicing medicine in Cherry Hill, New Jersey. Dr. Lacouture is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Anal Cancer, and Pleuropulmonary Blastoma. Dr. Lacouture is board certified in Radiology and Radiation Oncology. Dr. Lacouture is currently accepting new patients.

Matthew Stuart, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Dr. Stuart’s clinical interests include colorectal, pancreatic, gastrointestinal, lung, urological (GU) cancer, hematology, anemia, clotting disorders, lymphoma, multiple myeloma, and preventative care.Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, Dr. Stuart believes in treating the patient as a whole, implementing evidence-based, patient-centered, and cost-conscious care. His recent research includes evaluating race-based differences in treatment complications in patients with metastatic prostate cancer, improving vaccination rates in patients receiving chemotherapy, and providing community outreach to increase lung cancer screening and early detection.Dr. Stuart earned his medical degree at Rutgers New Jersey Medical School, Newark, NJ, where he served as director of the Student Family Health Care Center, the mini-medical school and premedical honors program, and the Institute for Public Understanding of Medicine in Action. He performed his internal medicine residency at Montefiore Medical Center, Bronx, NY, where he served on the Emergency-Internal Medicine and Resident Recruitment committees and received the Leo M. Davidoff Society Award for outstanding achievement in the teaching of medical students and a program innovation and improvement award. He remained at Montefiore to complete a fellowship in hematology/oncology, where he was named the chief hematology fellow and served on the Program Evaluation Committee. Following his fellowship training, he joined ACOHA in 2020.Fluent in conversational Spanish, Dr Stuart has presented at national and international medical conferences. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Stuart is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Stuart is board certified in American Board Of Internal Medicine. Dr. Stuart is currently accepting new patients.